Podnos Yale (Chief Medical Officer) reported special transactions (Non-P/S).
Podnos Yale (Chief Medical Officer) reported special transactions (Non-P/S).
Chernett Jorey () bought 2,899,355 shares at an average price of $3.9843 per common share (plus 4 other transaction types). (Date: 2026-11-10)
Chernett Jorey () bought 2,899,355 shares at an average price of $3.9843 per common share (plus 4 other transaction types). (Date: 2026-11-10)
(d) Exhibits Exhibit No. Description of Exhibit 99.1 Press release issued by Starling Oncology, Inc. on November 5, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the regi...
(d) Exhibits Exhibit No. Description of Exhibit 99.1 Press release issued by Starling Oncology, Inc. on November 5, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the regi...
https://www.stocktitan.net/news/STLN/starling-oncology-reports-third-quarter-2026-financial-results-and-262b5l3ym8yu.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/STLN/starling-oncology-reports-third-quarter-2026-financial-results-and-262b5l3ym8yu.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/STLN/starling-oncology-announces-third-quarter-2026-earnings-release-date-hc94sjs829jp.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/STLN/starling-oncology-announces-third-quarter-2026-earnings-release-date-hc94sjs829jp.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/STLN/starling-oncology-leadership-highlights-recent-and-upcoming-industry-o5t53q6hex87.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/STLN/starling-oncology-leadership-highlights-recent-and-upcoming-industry-o5t53q6hex87.html?utm_source=stocktitan-bluesky&utm_medium=social
No valid summary extracted.
No valid summary extracted.
Hively Brad () sold 298,853 shares at an average price of $6.5126 per common share. (Date: 2026-08-21)
Hively Brad () sold 298,853 shares at an average price of $6.5126 per common share. (Date: 2026-08-21)
$TOIIW 10-K → https://filingdiff.com/ticker/TOIIW/0001799191-26-000007/
$TOIIW 10-K → https://filingdiff.com/ticker/TOIIW/0001799191-26-000007/
$TOIIW 8-K → https://filingdiff.com/ticker/TOIIW/0001079973-26-000304/
$TOIIW 8-K → https://filingdiff.com/ticker/TOIIW/0001079973-26-000304/
$TOIIW 8-K → https://filingdiff.com/ticker/TOIIW/0001079973-26-000611/
$TOIIW 8-K → https://filingdiff.com/ticker/TOIIW/0001079973-26-000611/
$TOIIW 10-Q → https://filingdiff.com/ticker/TOIIW/0001799191-26-000010/
$TOIIW 10-Q → https://filingdiff.com/ticker/TOIIW/0001799191-26-000010/
On August 20, 2026, Starling Oncology Management, Limited Liability Company, a wholly owned subsidiary of Starling Oncology, Inc. , entered into a Credit Agreement among SOM, LLC, such other persons joined thereto as a borrower from time to time, and Gemino Healthcare Finance, LLC d/b/a ...
On August 20, 2026, Starling Oncology Management, Limited Liability Company, a wholly owned subsidiary of Starling Oncology, Inc. , entered into a Credit Agreement among SOM, LLC, such other persons joined thereto as a borrower from time to time, and Gemino Healthcare Finance, LLC d/b/a ...
BRADFORD HIVELY, a Director, filed a notice of intent to sell 298,853 shares of common stock, valued at approximately $1,954,498.62, on 08/21/2026.
BRADFORD HIVELY, a Director, filed a notice of intent to sell 298,853 shares of common stock, valued at approximately $1,954,498.62, on 08/21/2026.
Chernett Jorey () sold 12,000 shares at an average price of $6.5400 per common share (plus 1 other transaction types). (Date: 2026-08-13)
Chernett Jorey () sold 12,000 shares at an average price of $6.5400 per common share (plus 1 other transaction types). (Date: 2026-08-13)
On August 6, 2026, Starling Oncology, Inc. issued a press release announcing its financial results for the three months ended June 30, 2026 and certain other financial information.
On August 6, 2026, Starling Oncology, Inc. issued a press release announcing its financial results for the three months ended June 30, 2026 and certain other financial information.
Chernett Jorey () bought 18,000 shares at an average price of $5.2700 per common share. (Date: 2026-07-21)
Chernett Jorey () bought 18,000 shares at an average price of $5.2700 per common share. (Date: 2026-07-21)
Podnos Yale (Chief Medical Officer) sold 23,452 shares at an average price of $6.4105 per common share. (Date: 2026-07-14)
Podnos Yale (Chief Medical Officer) sold 23,452 shares at an average price of $6.4105 per common share. (Date: 2026-07-14)
YALE PODNOS, a Officer, filed a notice of intent to sell 23,452 shares of common stock, valued at approximately $146,575.00, on 07/14/2026.
YALE PODNOS, a Officer, filed a notice of intent to sell 23,452 shares of common stock, valued at approximately $146,575.00, on 07/14/2026.
Chernett Jorey () bought 15,000 shares at an average price of $5.8500 per common share. (Date: 2026-07-10)
Chernett Jorey () bought 15,000 shares at an average price of $5.8500 per common share. (Date: 2026-07-10)
TZOUMAKAS KIMBERLY JO () reported special transactions (Non-P/S).
TZOUMAKAS KIMBERLY JO () reported special transactions (Non-P/S).
STOLPER MARK () reported special transactions (Non-P/S).
STOLPER MARK () reported special transactions (Non-P/S).
On July 7, 2026, the Company issued a press release announcing the financings described in Item 1.01, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
On July 7, 2026, the Company issued a press release announcing the financings described in Item 1.01, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
Chernett Jorey () bought 18,000 shares at an average price of $5.0200 per common share. (Date: 2026-06-23)
Chernett Jorey () bought 18,000 shares at an average price of $5.0200 per common share. (Date: 2026-06-23)
No valid summary extracted.
No valid summary extracted.